A Word about… Rapid Influenza Diagnostic Testing (RIDT) Kelly L. Moore, MD, MPH Director, TN Immunization Program TDH Regional Epidemiology Meeting Montgomery.

Slides:



Advertisements
Similar presentations
Surveillance in a Pandemic: Situational Awareness
Advertisements

Diagnosis and Management of Acute HIV Infection HIV Clinical Guidelines from the New York State Department of Health AIDS Institute January 2010 HIV CLINICAL.
Prepared by Dr Alissar Rady, WHO Lebanon
The 10th International Congress of the Asian Society of Clinical Pathology and Laboratory Medicine September 10-11, 2009 in Ulaanbaatar Mongolia.
Tuberculosis in Children: Prevention Module 10C - March 2010.
Bioterrorist Agents: Tularemia
Genital Herpes Prevention and Clinical Services: What Should Health Departments Do Now? H. Hunter Handsfield, M.D. University of Washington Public Health.
Community Acquired Pneumonia Guidelines 2011 Top 11 Recommendations Michael H. Kim.
Mortality Among a Tuberculosis Outbreak Los Angeles County, 2007–2013 Brian Baker, MD Amit Chitnis, MD MPH Leslie Henry, BSN RN PHN 48th CTCA Educational.
Laboratory Diagnostics and Specimen Collection. Learning Objectives Know the basic components of specimen collection kits for use with suspect avian influenza.
Adriana Weinberg, MD University of Colorado Denver.
THE UNIFIED AIRWAY A CPMC Regional CME Event - An Integrated Approach Saturday October 1, 2011.
STUDY DESIGN FOR DIAGNOSTIC STUDY FOR MELIOIDOSIS Dr Direk Limmathurotsakul, MD MSc PhD.
Seasonal Influenza and Swine-Origin Influenza A (H1N1) Virus
SARS Timeline Nov 16 ‘02 Feb 11 ‘03 Feb 28 March 11 March 12 March 19 March 27 April 5 April 9 April 14 April 17 April 28 First cases Hong Kong WHO Sequence.
1 Module 5 Supplemental Information Laboratory Diagnostics, Specimen Collection, and Biosafety Issues.
Ebola Facts November 3, /3/14 Source: Centers for Disease Control and Prevention. This guidance is current as of Nov. 3, 2014 from
The laboratory investigation of urinary tract infections
Public Health Update David Kirschke, MD Medical Director / Health Officer Northeast Tennessee Regional Health Office.
Preventing HIV/AIDS There is no way to tell just by looking whether a person is infected with HIV. Because people are unaware that they are HIV-positive,
Cost-Conscious Care Presentation Follow-up Chest X-Ray in Patients Admitted for Community Acquired Pneumonia Huy Tran, PGY-2 12/12/2013.
Change in Physician Behavior Regarding Ordering Rapid Flu Test in Patients Hospitalized with Acute Lower Respiratory Tract Infections During Flu Season.
H1N1 General Information Update Karen Dahl, MD Pediatric Infectious Diseases.
Infectious Disease Epidemiology Section Office of Public Health Louisiana Department of Health and Hospitals
Martha Thompson, MPH Viral Isolation Team Leader Medical Virology Group Laboratory Services Section TX DSHS Influenza Surveillance Viral Isolation Laboratory.
Case Management of Suspect Human Avian Influenza Infection
The Importance of Viral Etiology in Hospitalized Patients with Community Acquired Pneumonia in Jefferson County Martin Gnoni MD, Swetha Kadali, MD, Jorge.
Learning from the 2009 H1N1 Pandemic Response 1 Daniel S. Miller MD, MPH Director, International Influenza Unit Office of the Secretary Office of Global.
Swine Influenza Information. Update as of 4/28/09 As of 11:00 AM there have been 64 cases reported in the USA. There has not been a confirmed case in.
Mycoplasmal pneumonia Pneumonia caused by Mycoplasma pneumoniae, often accompanied by pharyngitis and bronchitis.
U.S Novel H1N1 Influenza Meeting to Review the Surveillance System for AI and Pandemic Flu May 7, 2009 Rama Gardens Hotel Bangkok.
Outbreak of influenza A (H3N2) in a residence for mentally disabled persons in Ljubljana, Slovenia, 2013 Epidemiology and Public Health Valencia, Spain.
Smear negative TB and HIV: urgent research priorities to inform a rolling global policy Haileyesus Getahun, MD, MPH, PhD Stop TB Department WHO/HQ.
Influenza and the Nursing Home Population Julie L. Freshwater, PhD MPH Influenza Surveillance Coordinator 1.
SEARO –CSR Early Warning and Surveillance System Module Case Definitions.
Screening and Diagnostic Testing Sue Lindsay, Ph.D., MSW, MPH Division of Epidemiology and Biostatistics Institute for Public Health San Diego State University.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
SWINE FLU V.NEHRU ART CENTER KARUR. INTRODUCTION Swine flu is a respiratory disease of pigs caused by type A Influenza virus Swine flu is a respiratory.
US Situation Update and CDC International Response H1N1 Pandemic US Situation Update and CDC International Response Peter Nsubuga, MD, MPH On behalf of.
1 Novel Influenza A H1N1 Outbreak: The Florida Response Epidemiology Perspective: Situation Update.
Case Management of Suspect Avian Influenza A (H5N1) Virus Infection in Humans May, 2007.
Clinical Approach to the Diagnosis of SARS Joshua P. Metlay, MD, PhD VA Medical Center Division of General Internal Medicine Center for Clinical Epidemiology.
Avian Influenza H5N1 Prepared by: Samia ALhabardi.
Influenza Prevention and Treatment for the Season Faculty Stefan Gravenstein, MD, MPH Professor of Medicine The Center for Geriatric Medicine.
CDC Guidelines for Use of QuantiFERON ® -TB Gold Test Philip LoBue, MD Centers for Disease Control and Prevention Division of Tuberculosis Elimination.
Community Validation of Influenza-like Illness as a Predictor of Influenza Jonathan L. Temte, MD/PhD & Alexis Eastman, MS-2 University of Wisconsin School.
Laboratory Response to the 2009 H1N1 Event Texas Department of State Health Services Laboratory Services Section Grace Kubin, Ph.D. Vanessa Telles, MPH.
It’s Just Not the Flu Anymore Rick Hong, MD Associate Chairman CCHS EMC Medical Director, PHPS.
Viruses causing respiratory infections. Influenza viruses
Test 1Test 2Test 3Test 4Test 5Test 6 Sensitivity Specificity PPV NPV Performance.
Plans to Assess the Effectiveness of Seasonal and Pandemic Influenza Vaccines during David Shay MD, MPH (Prevention Assessment and Modeling Team.
Screening.  “...the identification of unrecognized disease or defect by the application of tests, examinations or other procedures...”  “...sort out.
Molecular Monitoring in CML the process and questions we can answer Letizia Foroni.
Risk factors for severe disease from pandemic (H1N1) 2009 virus infection reported to date are considered similar to those risk factors identified for.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
INFLUENZA DIVISION Update on the Epidemiology and Clinical Features of Novel H1N1 Joseph Bresee, MD Chief, Epidemiology and Prevention Branch Influenza.
Public Health Perspective on SARS Diagnostics Stephen M. Ostroff Deputy Director National Center for Infectious Diseases, CDC.
Screening & Investigation of Suspect Avian Influenza (H5N1) By Akrum Hamdy.
COMPARISON OF LABORATORY DIAGNOSTIC PROCEDURES FOR DETECTION OF MYCOPLASMA PNEUMONIAE IN COMMUNITY OUTBREAKS KATHLEEN A. THURMAN, NICHOLAS D. WALTER, STEPHANIE.
APIC Chapter 13 Journal Club March 16, 2015 Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults NEJM – July 30, :5 Presented.
Epidemiology of Human Infections with Avian Influenza A(H7N9) Virus in China Qun Li, M.D., Lei Zhou, M.D., Minghao Zhou, Ph.D., Zhiping Chen, M.D., Furong.
Infection Control Q and A APIC Greater NY Chapter 13 May 17, 2017 Beth Nivin BA MPH NYC DOHMH Communicable Disease Program
VIROLOGY “RESPIRATORY VIRUSES IN CYSTIC FIBROSIS”
Figure 1. Paradigm for evaluation of those with latent tuberculosis infection (LTBI) based on risk of infection, risk of progression to tuberculosis, and.
Nucleic Acid Amplification Test for Tuberculosis
بسم الله الرحمن الرحيم Clinical Epidemiology
CDC Guidelines for Use of QuantiFERON®-TB Gold Test
Is it Flu? Advances in Diagnostic Strategies and Implications for Patient Care.
Cedric Lazarus Livestock Development Officer
Laura Erhart, Shoana Anderson, Kelly Scranton
Presentation transcript:

A Word about… Rapid Influenza Diagnostic Testing (RIDT) Kelly L. Moore, MD, MPH Director, TN Immunization Program TDH Regional Epidemiology Meeting Montgomery Bell State Park April 30, 2014

RIDTs: Convenient but…how useful? Sensitivity (how likely is it to be positive if the patient has influenza) – 40-70%, but range of 10-80% has been reported vs. culture or RT-PCR Specificity (how likely it is to be positive for influenza and not other things) – 90-95% (range %). False negatives (missing it when it is there) more likely than false positives Recall “positive predictive value” PPV, “negative predictive value” NPV – Dependent on pre-test likelihood that the patient has the condition False-positive (and true-negative) more likely when virus not circulating widely – Beginning and end of the season and during summer False-negative (and true-positive) more likely when virus is circulating widely The Sentinel Provider Network is crucial – changes meaning of results

Minimize False Results Collect specimens as early in the illness as possible (ideally less than 4 days from illness onset). Follow manufacturer's instructions, including acceptable specimens, and handling. Follow-up negative results with confirmatory tests (RT- PCR or viral culture) if a laboratory-confirmed influenza diagnosis is desired. False negatives more likely if – Adult – Symptomatic 5 or more days – Upper respiratory specimen (e.g., nasal swab) When patient has lower respiratory tract disease

So you have RIDT results… When do you need real confirmation? Consider influenza testing by culture or RT- PCR to confirm results of an RIDT when: – RIDT negative + community influenza activity high + lab confirmation desired – RIDT positive + community influenza activity low + a false positive result is a consideration – Recent close exposure to pigs or poultry or other animals, novel influenza A infection possible

Testing Hospitalized Patients Influenza testing is recommended for hospitalized patients with suspected influenza. Empiric antiviral treatment should be initiated as soon as possible without the need to wait for influenza testing results Antiviral treatment should not be stopped based on negative RIDT results Implement infection control measures upon admission for any hospitalized patient with suspected influenza even if RIDT results negative Respiratory specimens can be tested for influenza by immunofluorescence, RT-PCR or viral culture. Serology is not for clinical management.

Conclusion Negative results of RIDTs do not exclude influenza virus infection Treatment should not be withheld from a patient hospitalized with signs and symptoms of influenza on the basis of RIDT results My view – Human psychology is can endanger patient lives in this situation – Instinct is for RIDT results to influence clinical judgment even when guidelines instruct one to ignore the RIDT Evidence suggests antivirals benefit hospitalized patients even if initiated after the first 2 days of illness Persons hospitalized with suspected influenza and not initiated on antiviral therapy are not given the best chance for recovery Treat the patient, not the test